TIL a study involving 165 patients with Alzheimer's found that those treated with the highest dose of an antibody drug, aducanumab, experienced an almost complete clearance of amyloid plaques (that supposedly lead to the irreversible memory loss and cognitive decline). User d_w_s, in the Today I Learned (TIL) subreddit, 15 Jan 2017
A team at Biogen reports positive clinical results of Amyloid-beta clearance and cognitive improvements following an antibody-based therapy for Alzheimer's Disease. User e_swartz, in the Science subreddit, 31 Aug 2016